Jiaping Peng
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
Papers in
-
- Inflammasome and immune disorders 2
- Angiogenesis and VEGF in Cancer 1
- Heat shock proteins research 1
- Gene expression and cancer classification 1
- Oncology 3
- Co-authors
- Shu Zheng (12 shared papers)Suzhan Zhang (5 shared papers)Xiyong Liu (2 shared papers)Yun Yen (2 shared papers)Peiguo Chu (2 shared papers)Lun Zhou (2 shared papers)Lily Lai (2 shared papers)Sofia Loera (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Journal of Zhejiang University. Science A (2 papers)Oncotarget (1 paper)Cell Communication and Signaling (1 paper)BMC Cancer (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Jiaping Peng
18 papers receiving 391 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 140
- Oncology 82
- Molecular Biology 209
- Pathology and Forensic Medicine 33
- Genetics 18
Countries citing papers authored by Jiaping Peng
This map shows the geographic impact of Jiaping Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping Peng more than expected).
Fields of papers citing papers by Jiaping Peng
This network shows the impact of papers produced by Jiaping Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping Peng. The network helps show where Jiaping Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaping Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 151 | |
| 2 | 2017 | 58 | |
| 3 | 2012 | 39 | |
| 4 | 2016 | 35 | |
| 5 | 2005 | 32 | |
| 6 | 2019 | 16 | |
| 7 | 2004 | 12 | |
| 8 | 2004 | 11 | |
| 9 | 2003 | 11 | |
| 10 | [Clinical analysis of 39 cases of heterotopic gastric mucosa in the upper esophagus]. | 2005 | 7 |
| 11 | 2005 | 7 | |
| 12 | [Expression and recombination mechanism of SNC73 (IgHalpha1) in human epithelial cancer cell line]. | 2003 | 4 |
| 13 | [Effect of microRNA143 expression on cell proliferation in colonic carcinoma]. | 2008 | 4 |
| 14 | 2005 | 3 | |
| 15 | 2005 | 2 | |
| 16 | 2004 | 1 | |
| 17 | [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line]. | 2003 | 1 |
| 18 | [Effects of microencapsulated CHO cells modified with maspin gene on the motility and adhesiveness of breast carcinoma cells Bcap37]. | 2005 | 1 |
About Jiaping Peng
Jiaping Peng is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Surgery, having authored 18 papers that have together received 395 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Heat shock proteins research (1 paper), Gene expression and cancer classification (1 paper), Immunotherapy and Immune Responses (1 paper), Bone and Dental Protein Studies (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Cancer Research (140 citations), Oncology (82 citations), Molecular Biology (209 citations), Pathology and Forensic Medicine (33 citations) and Genetics (18 citations). Jiaping Peng has collaborated with scholars based in China, United States and India. Frequent co-authors include Shu Zheng, Suzhan Zhang, Xiyong Liu, Yun Yen, Peiguo Chu, Lun Zhou, Lily Lai, Sofia Loera, Ying Yuan and Bingsen Zhou. Their work appears in journals such as Clinical Cancer Research, Journal of Zhejiang University. Science A, Oncotarget, Cell Communication and Signaling and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.